Gordian Biotechnology

Drug Discovery · San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. Gordian Biotechnology is based in San Francisco, CA and was founded in 2018. It was valued at $170 million at its early-stage round in Dec 2021, the last priced event on record. It has raised $60 million across 1 recorded round; the latest was a $1.5 million seed round in Apr 2020.

PMV mark · valuation
$170.0M
Oct 2026
Priced at
its early-stage round
Dec 2021
Total raised
$60.0M
Last round
Seed Round
Apr 2020

Who backs Gordian Biotechnology?

32 investors
InvestorType
Metaplanet HoldingsVenture capital
Founders FundVenture capital
StartX (US)Other
K5 GlobalVenture capital
Caffeinated Capital—
Johnson & Johnson Innovation - JLABSOther
Jeff DeanOther
Fifty YearsVenture capital
Horizons VenturesVenture capital
10x FoundersVenture capital
+ 22 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Gordian Biotechnology investors

32 investors are on record for Gordian Biotechnology, including Metaplanet Holdings, Founders Fund, StartX (US) and K5 Global. By type, the record holds 11 venture capital firms and 1 family office. The seed round in Apr 2020 drew 11 investors.

Free account
More of Gordian Biotechnology with a free account
  • ·The complete investor list: 32 names
  • ·Watch Gordian Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 32 firms already write checks for companies like Gordian Biotechnology in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View